Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
1. Body weight reduction at week 72 was significantly greater with tirzepatide versus placebo. 2. Hemoglobin A1c was significantly reduced ...







![ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg)

